Details for Patent: 7,638,522
✉ Email this page to a colleague
Title: | Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl- ]amino] benzonitrile |
Abstract: | The present invention relates to a pharmaceutical composition comprising as active ingredient the hydrochloric acid salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethyl-phenyl]amino]-2-pyrimidinyl]amino- ]benzonitrile and to processes for their preparation. |
Inventor(s): | Guillemont; Jerome Emile Georges (Ande, FR), Stevens; Paul Theodoor Agnes (Turnhout, BE), Copmans; Alex Herman (Lille, BE), Peeters; Jozef (Beerse, BE), Stappers; Alfred Elisabeth (Oud-Turnhout, BE), Vandecruys; Roger Petrus Gerebern (Westerlo, BE), Stoffels; Paul (Hoogstraten, BE) |
Assignee: | Janssen Pharmaceutica N.V. (Beerse, BE) |
Filing Date: | Sep 02, 2005 |
Application Number: | 11/219,163 |
Claims: | 1. A pharmaceutical composition comprising a pharmaceutically acceptable carrier and a compound of formula (I-a) ##STR00004## wherein said pharmaceutically acceptable carrier comprises: from 0.01 to 5% of said pharmaceutical composition of a wetting agent; from 40 to 92% of said pharmaceutical composition of a diluent; from 0 to 10% of said pharmaceutical composition of a polymer; from 2 to 10% of said pharmaceutical composition of a disintegrant; from 0.1 to 5% of said pharmaceutical composition of a glidant; and from 0.1 to 1.5% of said pharmaceutical composition of a lubricant; and wherein said compound of formula (I-a) is present in said pharmaceutical composition at from 5-50% of said pharmaceutical composition. |